Long term outcome and cost-effectiveness of stenting versus balloon angioplasty for acute myocardial infarction

Heart

Volumn 85, Issue 6, 2001, Pages 667-671

  Suryapranata, H ^a   Ottervanger, J P ^a   Nibbering, E ^a   Van't Hof, A W J ^a   Hoorntje, J C A ^a   De Boer, M J ^a   Al, M J ^a   Zijlstra, F ^a  

^a HOSPITAL DE WEEZENLANDEN   (Netherlands)

Author keywords

Angioplasty; Cost benefit analysis; Myocardial infarction; Stenting

Indexed keywords

ACUTE HEART INFARCTION; ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY STENT; COST EFFECTIVENESS ANALYSIS; FEMALE; FOLLOW UP; HEALTH CARE COST; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RESTENOSIS; TRANSLUMINAL CORONARY ANGIOPLASTY; TREATMENT OUTCOME;

EID: 0034768674     PISSN: 13556037     EISSN: None     Source Type: Journal    
DOI: 10.1136/heart.85.6.667     Document Type: Article

References (24)

1. Comparison of primary coronary angioplasty and intravenous thrombolytic therapy for acute myocardial infarction: A quantitative review
2. Long-term benefit of primary angioplasty as compared with thrombolytic therapy for acute myocardial infarction
3. Limitation of myocardial infarct size after primary angioplasty: Is a higher patency the only mechanism?
4. Coronary angioplasty with or without stent implantation for acute myocardial infarction
5. A comparison of systematic stenting and conventional balloon angioplasty during percutaneous transluminal coronary angioplasty for acute myocardial infarction
6. A clinical trial comparing primary stenting of the infarct-related artery with optimal primary angioplasty for acute myocardial infarction: Results from the Florence Randomized Elective Stenting in Acute Coronary Occlusion (FRESCO) trial
7. Primary stent implantation is superior to balloon angioplasty in acute myocardial infarction: Final results of the primary angioplasty versus stent implantation in acute myocardial infarction (PASTA) trial
8. In-hospital and late results of coronary stents versus conventional balloon angioplasty in acute myocardial infarction (GRAMI trial)
9. Randomized comparison of coronary stenting with balloon angioplasty in selected patients with acute myocardial infarction
10. Evaluating the potential cost-effectiveness of stenting as a treatment for symptomatic single-vessel coronary disease
11. Restenosis: The cost to society
12. In-hospital and one-year economic outcomes after coronary stenting or balloon angioplasty. Results from a randomized clinical trial
13. A comparison of balloon expandable stent implantation with balloon angioplasty in patients with coronary artery disease
14. A cost-effective analysis of primary coronary angioplasty versus thrombolysis for acute myocardial infarction
15. Cost effectiveness of stent implantation versus PTCA: The Benestent experience
16. Primary stent implantation without coumadin in acute myocardial infarction
17. Incidence and predictors of restenosis after successful primary coronary angioplasty for acute myocardial infarction: The importance of age and procedural result
18. Acute and long-term cost implications of coronary stenting
19. Economic outcomes analysis of stenting versus percutaneous transluminal coronary angioplasty for patients with coronary artery disease in Japan
20. The volume of primary angioplasty procedures and survival after acute myocardial infarction
21. Randomised comparison of implantation of heparin-coated stents with balloon angioplasty in selected patients with coronary artery disease (Benestent II)
22. Effect of glycoprotein IIb/IIIa receptor blockade on recovery of coronary flow and left ventricular function after the placement of coronary-artery stents in acute myocardial infarction
23. Abciximab in the treatment of acute myocardial infarction eligible for primary percutaneous transluminal coronary angioplasty. Results of the glycoprotein receptor antagonist patency evaluation (GRAPE) pilot study
24. Effect of glycoprotein IIb/IIIa inhibition without thrombolytic therapy on reperfusion in acute myocardial infarction: Results of ReoMI pilot study